Piramal Pharma (NSE:PPLPHARMA) Interest Expense : ₹-4,485 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Piramal Pharma's interest expense for the three months ended in Mar. 2024 was ₹ -1,142 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-4,485 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Piramal Pharma's Operating Income for the three months ended in Mar. 2024 was ₹ 3,338 Mil. Piramal Pharma's Interest Expense for the three months ended in Mar. 2024 was ₹ -1,142 Mil. Piramal Pharma's Interest Coverage for the quarter that ended in Mar. 2024 was 2.92. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Piramal Pharma Interest Expense Historical Data

The historical data trend for Piramal Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Interest Expense Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Interest Expense

-47.10

-1,887.80

-3,441.80

-4,484.90

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial							-1,042.50	-1,185.20	-1,098.70	-1,058.80	-1,142.20

Piramal Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4,485 Mil.

Piramal Pharma (NSE:PPLPHARMA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Piramal Pharma's Interest Expense for the three months ended in Mar. 2024 was ₹-1,142 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹3,338 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹26,017 Mil.

Piramal Pharma's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	3338	/	-1142.2
	=	2.92

The higher the ratio, the stronger the company's financial strength is.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Interest Expense

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines